TEST

Stakeholder Information.

Investors & Partners

Neurocentrx is seeking additional partners and funding to complete multiple Phase 2 and Phase 3 studies of its lead programmes. We welcome interest from new Investors as well as potential strategic partnerships.

Patients & Healthcare Professionals

We welcome potential strategic partnerships from patients & healthcare professionals as we continue to develop our range of oral ketamine.
Investors & Partners
Patients & Healthcare Professionals

Stakeholder Information.

Investors & Partners

Neurocentrx is seeking additional partners and funding to complete multiple Phase 2 and Phase 3 studies of its lead programmes. We welcome interest from new Investors as well as potential strategic partnerships.

Patients & Healthcare Professionals

We welcome potential strategic partnerships from patients & healthcare professionals as we continue to develop our range of oral ketamine.